Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 4, 2014, Pages 1013-1018

  Yang, Xingwang ^a   Jia, Mingguang ^a   Li, Zhaodong ^b   Lu, Shiyong ^a   Qi, Xiangjie ^a   Zhao, Bo ^a   Wang, Xiaoming ^a   Rong, Yu ^a   Shi, Jian ^c   Zhang, Zhijun ^a   Xu, Weizhi ^a   Gao, Yujun ^a   Zhang, Shuliang ^a   Yu, Gang ^a,c  

^a Departments of Surgery   (China)

^b Department of Radiology ^*  (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Aggressive behavior; breast cancer; integrated gene regulatory network

Indexed keywords

MICRORNA; TRANSCRIPTION FACTOR; HORMONE; TRANSCRIPTOME;

ARTICLE; BIOINFORMATICS; BREAST CANCER; BREAST CANCER CELL LINE; CAV1 GENE; CD44 GENE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FN1 GENE; FOCAL ADHESION; GENE; GENE EXPRESSION; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETIC IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; TGFBETAP2 GENE; BIOLOGY; BREAST TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR INVASION;

BREAST NEOPLASMS; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HORMONES; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84921421414     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.137971     Document Type: Article

References (47)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Debily MA, El Marhomy S, Boulanger V, Eveno E, Mariage-Samson R, Camarca A, et al. A functional and regulatory network associated with PIP expression in human breast cancer. PloS One 2009;4:e4696.
3. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: Markers and models. Nat Rev Cancer 2005;5:591-602.
4. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 2001;61:5168-78.
5. Hayes DF, Trock B, Harris AL. Assessing the clinical impact of prognostic factors: When is «statistically significant» clinically useful Breast Cancer Res Treat 1998;52:305-19.
6. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 2003;100:11606-11.
7. Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 2002;20L719-26.
8. Ventura A, Jacks T. MicroRNAs and cancer: Short RNAs go a long way. Cell 2009;136:586-91.
9. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449:682-8.
10. Luo D, Wilson JM, Harvel N, Liu J, Pei L, Huang S, et al. A systematic evaluation of miRNA: mRNA interactions involved in the migration and invasion of breast cancer cells. J Transl Med 2013;11:57.
11. Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietilaïnen T, Böhm J, et al. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Clin Cancer Res 2002;8:3487-95.
12. Wagoner MP, Gunsalus KT, Schoenike B, Richardson AL, Friedl A, Roopra A. The transcription factor REST is lost in aggressive breast cancer. Plos Genet 2010;6:e1000979.
13. Team R. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2007. ISBN 3-900051-07-0, 2012.
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
15. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:3.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 1995;57: 289-300.
17. Jiang C, Xuan Z, Zhao F, Zhang MQ. TRED: A transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 2007;35:D137-40.
18. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Res 2009;37:D105-10.
19. Sethupathy P, Corda B, Hatzigeorgiou AG. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 2006;12:192-7.
20. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: A database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 2011;39:D202-9.
21. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, et al. miR2Disease: A manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 2009;37:D98-104.
22. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504.
23. Masoudi-Nejad A, Schreiber F, Kashani Z. Building blocks of biological networks: A review on major network motif discovery algorithms. IET Syst Biol 2012;6:164-74.
24. Wernicke S, Rasche F. FANMOD: A tool for fast network motif detection. Bioinformatics 2006;22:1152-3.
25. Da Wei Huang BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2008;4:44-57.
26. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93-103.
27. Wray GA, Hahn MW, Abouheif E, Balhoff JP, Pizer M, Rockman MV, et al. The evolution of transcriptional regulation in eukaryotes. Mol Biol Evol 2003;20:1377-419.
28. Cheng C, Yan KK, Hwang W, Qian J, Bhardwaj N, Rozowsky J, et al. Construction and analysis of an integrated regulatory network derived from high-throughput sequencing data. Plos Comput Biol 2011;7:e1002190.
29. Barabási AL, Oltvai ZN. Network biology: Understanding the cell's functional organization. Nat Rev Genet 2004;5:101-13.
30. Stites EC, Trampont PC, Ma Z, Ravichandran KS. Network analysis of oncogenic Ras activation in cancer. Science 2007;318:463-7.
31. Chen WX, Hu Q, Qiu MT, Zhong SL, Xu JJ, Tang JH, et al. miR-221/222: Promising biomarkers for breast cancer. Tumor Biol 2013;34:1361-70.
32. Ha TK, Chi SG. CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription. Autophagy 2012;8:1684-5.
33. Sherif ZA, Sultan AS. Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines. Cancer Biol Ther 2013;14:29-38.
34. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing «preassembled signaling complexes» at the plasma membrane. J Biol Chem 1998;273:5419-22.
35. Hayashi K, Matsuda S, Machida K, Yamamoto T, Fukuda Y, Nimura Y, et al. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res 2001;61:2361-4.
36. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998;16:1391-7.
37. Williams TM, Lisanti MP. The caveolin proteins. Genome Biol 2004;5:214.
38. Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours. Eur J Cancer 2010;46:1271-7.
39. Culty M, Shizari M, Thompson EW, Underhill CB. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential. J Cell Physiol 1994;160:275-86.
40. Huang SS, Huang JS. TGF-® control of cell proliferation. J Cell Biochem 2005;96:447-62.
41. Galliher AJ, Schiemann WP. Src phosphorylates Tyr284 in TGF-® type II receptor and regulates TGF-® stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 2007;67:3752-8.
42. Lempiaïnen H, Shore D. Growth control and ribosome biogenesis. Curr Opin Cell Biol 2009;21:855-63.
43. Ray S, Johnston R, Campbell DC, Nugent S, McDade SS, Waugh D, et al. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner. Gene 2013;526:46-53.
44. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP. Caveolin-1 interacts with androgen receptor A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001;276:13442-51.
45. Drosten M, Dhawahir A, Sum EY, Urosevic J, Lechuga CG, Esteban LM, et al. Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. EMBO J 2010;29:1091-104.
46. Chen J, Xia J, Wang S, Wei Y, Wu J, Huang G, et al. Study on transcription regulation network in rheumatoid arthritis via bioinformatics analysis. Afr J Pharm Pharmacol 2012;6:1435-43.
47. Howe EN, Cochrane DR, Richer JK. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 2011;13:R45.